FR2810243B1 - Timbre transdermique pour medicaments anti-inflammatoires non steroidiens - Google Patents

Timbre transdermique pour medicaments anti-inflammatoires non steroidiens

Info

Publication number
FR2810243B1
FR2810243B1 FR0007752A FR0007752A FR2810243B1 FR 2810243 B1 FR2810243 B1 FR 2810243B1 FR 0007752 A FR0007752 A FR 0007752A FR 0007752 A FR0007752 A FR 0007752A FR 2810243 B1 FR2810243 B1 FR 2810243B1
Authority
FR
France
Prior art keywords
steroidian
transdermal
stamp
inflammatory medicines
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0007752A
Other languages
English (en)
Other versions
FR2810243A1 (fr
Inventor
Yan Poy Woo
Sung Min Cho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sang A Pharmaceutical Co Ltd
Original Assignee
Sang A Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/577,787 priority Critical patent/US6455067B1/en
Priority to GB0013337A priority patent/GB2362825B/en
Priority to DE10026678A priority patent/DE10026678C1/de
Application filed by Sang A Pharmaceutical Co Ltd filed Critical Sang A Pharmaceutical Co Ltd
Priority to FR0007752A priority patent/FR2810243B1/fr
Publication of FR2810243A1 publication Critical patent/FR2810243A1/fr
Application granted granted Critical
Publication of FR2810243B1 publication Critical patent/FR2810243B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0007752A 2000-05-24 2000-06-16 Timbre transdermique pour medicaments anti-inflammatoires non steroidiens Expired - Fee Related FR2810243B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US09/577,787 US6455067B1 (en) 2000-05-24 2000-05-24 Transdermal patch for nonsteroidal antiinflammatory drug(s)
GB0013337A GB2362825B (en) 2000-05-24 2000-06-01 Transdermal patch for nonsteroidal antiinflammatory drug(s)
DE10026678A DE10026678C1 (de) 2000-05-24 2000-06-01 Transdermales Pflaster für einen entzündungshemmenden Wirkstoff oder für entzündungshemmende Wirkstoffe
FR0007752A FR2810243B1 (fr) 2000-05-24 2000-06-16 Timbre transdermique pour medicaments anti-inflammatoires non steroidiens

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/577,787 US6455067B1 (en) 2000-05-24 2000-05-24 Transdermal patch for nonsteroidal antiinflammatory drug(s)
GB0013337A GB2362825B (en) 2000-05-24 2000-06-01 Transdermal patch for nonsteroidal antiinflammatory drug(s)
DE10026678A DE10026678C1 (de) 2000-05-24 2000-06-01 Transdermales Pflaster für einen entzündungshemmenden Wirkstoff oder für entzündungshemmende Wirkstoffe
FR0007752A FR2810243B1 (fr) 2000-05-24 2000-06-16 Timbre transdermique pour medicaments anti-inflammatoires non steroidiens

Publications (2)

Publication Number Publication Date
FR2810243A1 FR2810243A1 (fr) 2001-12-21
FR2810243B1 true FR2810243B1 (fr) 2003-09-19

Family

ID=27437827

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0007752A Expired - Fee Related FR2810243B1 (fr) 2000-05-24 2000-06-16 Timbre transdermique pour medicaments anti-inflammatoires non steroidiens

Country Status (4)

Country Link
US (1) US6455067B1 (fr)
DE (1) DE10026678C1 (fr)
FR (1) FR2810243B1 (fr)
GB (1) GB2362825B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074421B2 (en) * 2000-06-06 2006-07-11 Teijin Limited Member for application of ointment and ointment patch employing the same
JP3763567B2 (ja) * 2001-01-19 2006-04-05 株式会社資生堂 化粧料
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
DE10142918A1 (de) * 2001-09-01 2003-05-22 Beiersdorf Ag Selbstklebende Gelmatrix auf Polyacrylsäurebasis
US20030180347A1 (en) * 2002-03-19 2003-09-25 W.F. Young, Incorporated Patch for the delivery of topical agents
US8034374B2 (en) * 2003-03-18 2011-10-11 Hisamitsu Pharmaceutical Co., Inc. Patch containing nonsteroidal anti-inflammatory and analgesic agent
SE526313C2 (sv) * 2003-12-17 2005-08-23 Moelnlycke Health Care Ab Sårvårdsprodukt innehållande ett ämne som hämmar tillväxt av bakterier i sår
EP1846009A2 (fr) * 2005-02-11 2007-10-24 NOLabs AB Dispositif d'application de medicaments ameliore, procede de fabrication de celui-ci et procede de traitement
US7485323B2 (en) * 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
US7943668B2 (en) * 2008-03-03 2011-05-17 Altergon S.A. Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained
DE102008015299A1 (de) 2008-03-18 2009-09-24 Pkh Gmbh Halle Kolloidales Trägersystem
JP4879928B2 (ja) * 2008-03-25 2012-02-22 帝國製薬株式会社 ケトプロフェンリジン塩を含有する水性貼付剤
CA2735418A1 (fr) * 2008-08-26 2010-03-11 Ray L. Hauser Administration de substance a la peau et autres tissus
US20090318568A1 (en) * 2009-08-26 2009-12-24 Hauser Ray L Adherent coating for tissue surface and/or trans-tissue surface substance delivery
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9744132B2 (en) * 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9737500B2 (en) * 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
SG11201505245XA (en) * 2013-01-14 2015-08-28 Infirst Healthcare Ltd Compositions and methods for treating severe pain
CA2897878A1 (fr) * 2013-01-14 2014-07-17 Infirst Healthcare Limited Compositions de solutions solides et utilisation dans le traitement d'une maladie cardiovasculaire
MX366317B (es) * 2013-02-04 2019-07-03 Infirst Healthcare Ltd Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
JP6616941B2 (ja) * 2013-11-29 2019-12-04 花王株式会社 抗炎症剤及びメラニン生成抑制剤
CN105960234A (zh) * 2014-02-27 2016-09-21 久光制药株式会社 含有酮洛芬的巴布剂
JP6676548B2 (ja) * 2015-01-30 2020-04-08 株式会社 メドレックス 水性外用剤
CN115337289A (zh) * 2020-07-29 2022-11-15 湖南九典制药股份有限公司 含有右酮洛芬或其药用盐的凝胶贴膏基质及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61212516A (ja) * 1985-03-18 1986-09-20 Toyobo Co Ltd ピロキシカム軟膏剤
JPH06104624B2 (ja) * 1986-05-07 1994-12-21 太郎 小木曽 経皮吸収剤
JPH0696526B2 (ja) * 1986-12-10 1994-11-30 佐藤製薬株式会社 メフエナム酸外用液剤
JP2820306B2 (ja) * 1990-02-27 1998-11-05 積水化学工業株式会社 経皮吸収製剤
CA2121603A1 (fr) * 1991-11-15 1993-05-16 Hirohisa Okuyama Platre antiphlogistique et analgesique
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
EP0676962B9 (fr) * 1992-12-31 2002-04-03 Sunkyong Industries Co., Ltd. Compositions pharmaceutiques assurant une absorption percutanee amelioree pour piroxicam
JP2920451B2 (ja) * 1993-03-29 1999-07-19 エスエス製薬株式会社 消炎鎮痛貼付剤
EP0695179A1 (fr) * 1993-04-22 1996-02-07 Minnesota Mining And Manufacturing Company Composition transdermique anti-inflammatoire
AU667161B2 (en) * 1993-04-28 1996-03-07 Daiichi Pharmaceutical Co., Ltd. Butyrophenone transdermal compositions
JP3382032B2 (ja) * 1994-10-14 2003-03-04 埼玉第一製薬株式会社 インドメタシン貼付剤
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
DE19830649C2 (de) * 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe

Also Published As

Publication number Publication date
GB2362825A (en) 2001-12-05
GB0013337D0 (en) 2000-07-26
DE10026678C1 (de) 2002-03-21
GB2362825B (en) 2003-09-24
FR2810243A1 (fr) 2001-12-21
US6455067B1 (en) 2002-09-24

Similar Documents

Publication Publication Date Title
FR2810243B1 (fr) Timbre transdermique pour medicaments anti-inflammatoires non steroidiens
NO20020464D0 (no) Flerkomponent-farmasöytisk doseringsform
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
NO20031915L (no) Dispenser for medikament
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
DK1524266T3 (da) Farmaceutisk sammensætning
MA26621A1 (fr) Composition pour aerosols pharmaceutiques
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
IL142037A0 (en) Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
NO20014926L (no) Farmasöytiske forbindelser
ITMI20001827A0 (it) Medicamento antinfiammatorio
ATE348599T1 (de) Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
AR026072A1 (es) Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
FI5176U1 (fi) Sitalopraamia sisältävä farmaseuttinen koostumus
EE200100281A (et) Analgeetiline ravimkoostis
NO20031650L (no) Nye legemidler for leversykdommer
EA200201062A1 (ru) Фармацевтическая композиция на основе нестероидного противовоспалительного средства
EE200300378A (et) Farmatseutiline kompositsioon
FI20011446A0 (fi) Farmaseuttinen, brivudiinia sisältävä, kerran päivässä käytettävä koostumus
AU3279900A (en) Pharmaceutical topical compositions containing a non-steroidal antiinflammatory drug
SE9904819D0 (sv) A new pharmaceutical composition
DE50008261D1 (de) Retardierte darreichungsform enthaltend tramadolsaccharinat
UA4809S (uk) Упаковка для ліків

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20100226